INBX

Inhibrx Biosciences Stock Analysis

AI Rating

Fair
  • Quality6/10
  • Growth↑ 7/10
  • Value↓ 0/10
Inhibrx Biosciences sales and earnings growth
INBX Growth
Good
  • Revenue Y/Y↑ 544.16%
  • EPS Y/Y↓ -107.21%
  • FCF Y/Y↑ 21.82%
Inhibrx Biosciences gross and profit margin trends
INBX Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -10014.20%
  • ROIC 5Y↓ 0.00%
Inhibrx Biosciences net debt vs free cash flow
INBX Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.1
  • Interest coverage↓ -9.0

Inhibrx Biosciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks